Biopolis Lifesciences Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 01-07-2024
- Paid Up Capital ₹ 0.50 M
as on 01-07-2024
- Company Age 6 Year, 11 Days
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 4.90 M
as on 01-07-2024
- Revenue 56.76%
(FY 2022)
- Profit 85.66%
(FY 2022)
- Ebitda -74.62%
(FY 2022)
- Net Worth 79.46%
(FY 2022)
- Total Assets 75.19%
(FY 2022)
About Biopolis Lifesciences
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.50 M.
The company currently has active open charges totaling ₹4.90 M.
Jatinder Sharda and Gopal Krishna serve as directors at the Company.
- CIN/LLPIN
U24110CH2018PTC042178
- Company No.
042178
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
25 Sep 2018
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Chandigarh
Industry
Company Details
- Location
Chandigarh, Chandigarh, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Biopolis Lifesciences Private Limited offer?
Biopolis Lifesciences Private Limited offers a wide range of products and services, including Digestive System Drugs & Medicines, Gastrointestinal Drugs, Anti Infective Drugs & Medicines, Antibiotic Tablets, Capsule & Syrup, Antacid Drugs, Anti Allergic Drug, Nutraceuticals & Dietary Supplements, Vitamin Tablets & Capsules, Fitness Supplements, Antifungal Cream, Ointment & Powder.
Who are the key members and board of directors at Biopolis Lifesciences?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Jatinder Sharda  | Director | 25-Sep-2018 | Current |
| Gopal Krishna | Director | 25-Sep-2018 | Current |
Financial Performance and Corporate Structure Insights of Biopolis Lifesciences.
Biopolis Lifesciences Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 56.76% increase. The company also saw a substantial improvement in profitability, with a 85.66% increase in profit. The company's net worth Soared by an impressive increase of 79.46%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Biopolis Lifesciences?
In 2020, Biopolis Lifesciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Derma 360 Private Limited
Active
2 years 8 months Jatinder Sharda and Gopal Krishna are mutual person
Aclivia Healthcare Private Limited
Active 1 year 10 months Jatinder Sharda and Gopal Krishna are mutual person
One Wellness International Private Limited
Active 4 years 1 month Jatinder Sharda and Gopal Krishna are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 09 May 2023 | ₹4.90 M | Open |
How Many Employees Work at Biopolis Lifesciences?
Unlock and access historical data on people associated with Biopolis Lifesciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Biopolis Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Biopolis Lifesciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
